SCHEMBL6855829

SCHEMBL6855829

CC(CS)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474784 0.75
SCHEMBL7044962 0.72
SCHEMBL22821849 0.72
SCHEMBL33628 0.69
SCHEMBL727539 0.69
SCHEMBL13662042 0.69
SCHEMBL12161815 0.69
SCHEMBL12354688 0.69
SCHEMBL12886405 0.69
SCHEMBL9636387 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828315-B1 Anti- inflammatories, anti-allergics, bronchodilatators, anti-asthmatics, or TNF alpha inhibitors WARNER-LAMBERT LLC 2004-12-07 US claimed
US-20230014137-A1 COMPOUND HAVING LYSOPHOSPHATIDIC ACID RECEPTOR AGONIST ACTIVITY AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed
WO-2021107125-A1 COMPOUND HAVING LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTIC ACTIVITY AND PHARMACEUTICAL USE OF SAID COMPOUND 小野薬品工業株式会社 2021-06-03 WO disclosed
CN-109320574-B Industrial preparation method of cangrelor intermediate 北京桦冠生物技术有限公司 2021-01-05 CN disclosed
CN-109320574-A A kind of industrialized process for preparing of cangrelor intermediate 北京桦冠医药科技有限公司 2019-02-12 CN disclosed